Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis

被引：0

作者：

Elewski, B. E. ^{[1
]}

Staender, S. ^{[2
,3
]}

Zirwas, M. ^{[4
]}

Silvestre, J. F. ^{[5
]}

Kalia, S. ^{[6
,7
,8
]}

Gutermuth, J. ^{[9
,10
]}

Mark, T. ^{[11
]}

Tindberg, A. M. ^{[11
]}

Silverberg, J. I. ^{[12
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Univ Hosp Munster, Dept Dermatol, Munster, Germany

[3] Univ Hosp Munster, Interdisciplinary Competence Ctr Chron Pruritus K, Munster, Germany

[4] Prob Med Res, Columbus, OH USA

[5] Hosp Gen Univ Alicante, Dermatol Dept, Alicante, Spain

[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada

[7] Vancouver Coastal Hlth, Vancouver, BC, Canada

[8] BC Childrens Hosp Res Inst, Vancouver, BC, Canada

[9] Univ Ziekenhuis Brussel, Dept Dermatol, Brussels, Belgium

[10] Vrije Univ Brussel, Brussels, Belgium

[11] LEO Pharma AS, Ballerup, Denmark

[12] George Washington Univ, Sch Med & Hlth Sci, Depat Dermatol, Washington, DC 20052 USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

385

引用

页码：E83 / E84

页数：2

共 50 条

[11] Tralokinumab real-world patient-reported outcomes in moderate-to-severe atopic dermatitis adult patients in the United States: 6-month interim analysis [J].

Lio, Peter ;

Kim, Yestle ;

Balu, Sanjeev ;

Costantino, Halley ;

Bates, Dawn ;

Rene, Cassandra ;

Lopez, Amanda ;

Soung, Jennifer .

BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 :II50-II51

[12] Dupilumab Improves Patient-Reported Outcomes (PROs) in a Phase 2 Study in Adults with Moderate-to-Severe Atopic Dermatitis [J].

Simpson, Eric ;

Worm, Margitta ;

Soong, Weily ;

Blauvelt, Andrew ;

Eckert, Laurent ;

Wu, Richard ;

Ardeleanu, Marius ;

Graham, Neil ;

Pirozzi, Gianluca ;

Sutherland, E. Rand ;

Mastey, Vera .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) :AB167-AB167

[13] Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis [J].

Jonathan I. Silverberg ;

David N. Adam ;

Matthew Zirwas ;

Sunil Kalia ;

Jan Gutermuth ;

Andreas Pinter ;

Andrew E. Pink ;

Andrea Chiricozzi ;

Sebastien Barbarot ;

Thomas Mark ;

Ann-Marie Tindberg ;

Stephan Weidinger .

American Journal of Clinical Dermatology, 2022, 23 :547-559

[14] Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials [J].

Reich, K. ;

DeLozier, A. M. ;

Nunes, F. P. ;

Thyssen, J. P. ;

Eichenfield, L. F. ;

Wollenberg, A. ;

Terres, J. A. Ross ;

Watts, S. D. ;

Chen, Y-F ;

Simpson, E. L. ;

Silverberg, J., I .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) :1521-1530

[15] Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis [J].

Silverberg, Jonathan, I ;

Adam, David N. ;

Zirwas, Matthew ;

Kalia, Sunil ;

Gutermuth, Jan ;

Pinter, Andreas ;

Pink, Andrew E. ;

Chiricozzi, Andrea ;

Barbarot, Sebastien ;

Mark, Thomas ;

Tindberg, Ann-Marie ;

Weidinger, Stephan .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (04) :547-559

[16] High burden of patient-reported ocular disorders and symptoms in adults with moderate-to-severe atopic dermatitis [J].

Weyne, J. ;

Blauvelt, A. ;

de Bruin-Weller, M. ;

Prens, E. ;

Asbell, P. ;

Sierka, D. ;

Chen, Z. ;

Shumel, B. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) :S53-S53

[17] Atopic dermatitis: Patient characteristics and patient-reported outcomes on topical therapy [J].

Anderson, P. ;

Austin, J. ;

Lofland, J. ;

Piercy, J. ;

Joish, V. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) :S58-S58

[18] Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis [J].

Merola, Joseph F. ;

Butler, Daniel C. ;

Mark, Thomas ;

Schneider, Shannon ;

Kim, Yestle ;

Abuabara, Katrina .

JAMA DERMATOLOGY, 2023, 159 (10) :1119-1123

[19] Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice [J].

Schloesser, Anne R. ;

Shareef, Madena ;

Olydam, Jill ;

Nijsten, Tamar E. C. ;

Hijnen, Dirk Jan .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (05) :510-517

[20] Greater severity of atopic dermatitis (AD) is associated with poorer patient-reported outcomes among adults with moderate-to-severe AD [J].

Nyberg, Fredrik ;

Hansen, Jes B. ;

Andersen, Line .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 :334-334

← 1 2 3 4 5 →